Ovid Therapeutics (OVID) Intangibles (2016 - 2022)
Ovid Therapeutics' Intangibles was $244,000 in Q1 2022, down 7.2% from $263,000 a year earlier and down 7.2% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Intangibles (2016 - 2022) Analysis & Trends
At the end of FY2021, Intangibles at Ovid Therapeutics came in at $263,000, down 17.6% from FY2020.
- Intangibles shows a five-year compound annual growth rate of 19.0% (FY2016 to FY2021).
- In earlier years, Intangibles was $319,000 in FY2020 (-31.7%), $467,000 in FY2019 (+19.1%), $392,000 in FY2018 (+215.6%) and $124,194 in FY2017 (+12.8%).
- Quarterly Intangibles has moved between $121,323 (Q3 2017) and $467,000 (Q4 2019) over five years.
- Compared with a year earlier, Intangibles has declined for six straight quarters, with an average decline of 17.5% over the last eight quarters.
- The best year-over-year quarter for Intangibles over five years was Q3 2018 (growth of 234.7%); the worst was Q3 2021 (a decline of 45.4%).
- Per Business Quant data, OVID's Intangibles in the three quarters before Q1 2022 was $263,000 (Q4 2021), $197,000 (Q3 2021) and $227,000 (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Ovid Therapeutics | 460.04 Mn | 92.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 244,000.00 |
| Dec 31, 2021 | 263,000.00 |
| Sep 30, 2021 | 197,000.00 |
| Jun 30, 2021 | 227,000.00 |
| Mar 31, 2021 | 263,000.00 |
| Dec 31, 2020 | 319,000.00 |
| Sep 30, 2020 | 361,000.00 |
| Jun 30, 2020 | 376,000.00 |
| Mar 31, 2020 | 436,000.00 |
| Dec 31, 2019 | 467,000.00 |
| Sep 30, 2019 | 351,000.00 |
| Jun 30, 2019 | 271,000.00 |
| Mar 31, 2019 | 331,000.00 |
| Dec 31, 2018 | 392,000.00 |
| Sep 30, 2018 | 406,078.00 |
| Jun 30, 2018 | 313,333.00 |
| Mar 31, 2018 | 160,390.00 |
| Dec 31, 2017 | 124,194.00 |
| Sep 30, 2017 | 121,323.00 |
| Jun 30, 2017 | 131,100.00 |
API Access
Ovid Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();